FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 101 through 150 of 320

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
CYCN Nasdaq Cyclerion Therapeutics, Inc. 2836
DCOY Nasdaq Decoy Therapeutics Inc. 2836
DCTH Nasdaq Delcath Systems, Inc. 2836
DMAC Nasdaq DiaMedica Therapeutics Inc. 2836
DNTH Nasdaq Dianthus Therapeutics, Inc. 2836
DRUG Nasdaq Bright Minds Biosciences Inc. 2836
DSGN Nasdaq Design Therapeutics, Inc. 2836
DTIL Nasdaq Precision BioSciences, Inc. 2836
DYAI Nasdaq Dyadic International, Inc. 2836
DYN Nasdaq Dyne Therapeutics, Inc. 2836
EBS New York Emergent BioSolutions Inc. 2836
EIKN Nasdaq Eikon Therapeutics, Inc. 2836
ELUT Nasdaq Elutia Inc. 2836
ELVN Nasdaq Enliven Therapeutics, Inc. 2836
ENLV Nasdaq Enlivex Ltd. 2836
ENTA Nasdaq Enanta Pharmaceuticals, Inc. 2836
ENTX Nasdaq Entera Bio Ltd. 2836
ERAS Nasdaq Erasca, Inc. 2836
ERNA Nasdaq Ernexa Therapeutics Inc. 2836
ESLA Nasdaq Estrella Immunopharma, Inc. 2836
ESPR Nasdaq Esperion Therapeutics, Inc. 2836
EVAX Nasdaq Evaxion A/S 2836
EVGN Nasdaq Evogene Ltd. 2836
EXEL Nasdaq Exelixis, Inc. 2836
EXOZ Nasdaq eXoZymes, Inc. 2836
FATE Nasdaq Fate Therapeutics, Inc. 2836
FBLG Nasdaq FibroBiologics, Inc. 2836
FHTX Nasdaq Foghorn Therapeutics Inc. 2836
FULC Nasdaq Fulcrum Therapeutics, Inc. 2836
GALT Nasdaq Galectin Therapeutics Inc. 2836
GANX Nasdaq Gain Therapeutics, Inc. 2836
GENB Nasdaq Generate Biomedicines, Inc. 2836
GENSY Over the counter Genus plc 2836
GHRS Nasdaq GH Research PLC 2836
GILD Nasdaq Gilead Sciences, Inc. 2836
GLSI Nasdaq Greenwich LifeSciences, Inc. 2836
GMAB Nasdaq Genmab A/S 2836
GMED New York Globus Medical, Inc. 2836
GNPX Nasdaq Genprex, Inc. 2836
GOSS Nasdaq Gossamer Bio, Inc. 2836
GRAL Nasdaq GRAIL, Inc. 2836
GRML Nasdaq Greenland Mines Ltd 2836
GTBP Nasdaq GT Biopharma, Inc. 2836
GYRE Nasdaq Gyre Therapeutics, Inc. 2836
HALO Nasdaq Halozyme Therapeutics, Inc. 2836
HBIO Nasdaq Harvard Bioscience, Inc. 2836
HCWB Nasdaq HCW Biologics Inc. 2836
HOWL Nasdaq Werewolf Therapeutics, Inc. 2836
HRGN Over the counter Harvard Apparatus Regenerative Technolog 2836
HUMA Nasdaq Humacyte, Inc. 2836
Results 100 through 150 of 320